Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan · Delayed Price · Currency is TWD 48.00
-2.70 (-5.33%)
Apr 17, 2026, 1:30 PM CST
Medigen Vaccine Biologics Market Cap
Medigen Vaccine Biologics has a market cap or net worth of 15.78 billion as of April 17, 2026. Its market cap has decreased by -10.78% in one year.
Market Cap
15.78B
Enterprise Value
14.29B
Revenue
613.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
48.00
Market Cap Chart
Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 15.78B, an increase of 456.61%. That is a compound annual growth rate of 17.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 15.78B | 27.15% |
| Dec 31, 2025 | 12.41B | 4.72% |
| Dec 31, 2024 | 11.85B | -48.55% |
| Dec 29, 2023 | 23.04B | 1.10% |
| Dec 30, 2022 | 22.78B | -64.20% |
| Dec 30, 2021 | 63.65B | 192.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 26.07B |
| Lumosa Therapeutics | 21.94B |
| Sunmax Biotechnology | 21.65B |
| AP Biosciences | 16.69B |
| Polaris Group | 16.17B |
| EirGenix | 15.31B |
| TaiMed Biologics | 14.56B |
| Ever Supreme Bio Technology | 12.26B |